Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cicatricial pemphigoid.

A R Ahmed1, B S Kurgis, R S Rogers

  • 1Center for Blood Research, Boston, MA 02115.

Journal of the American Academy of Dermatology
|June 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pemphigoid of the pulmonary system.

Annales de dermatologie et de venereologie·2024
Same author

Association of HMGBP1 expression with clinical periimplant parameters among smokers and never-smokers with and without peri-implantitis.

European review for medical and pharmacological sciences·2022
Same author

Assessment of radiographic morphology of mandibular condyles: a radiographic study.

Folia morphologica·2021
Same author

Simple tool to prioritize access to bariatric surgery for people living with obesity during the COVID-19 pandemic.

The British journal of surgery·2021
Same author

Should Oral Sodium Bicarbonate Be Used to Prevent Chronic Kidney Disease Progression?

Irish medical journal·2020
Same author

Tracking physical activity using smart phone apps: assessing the ability of a current app and systematically collecting patient recommendations for future development.

BMC medical informatics and decision making·2020

Cicatricial pemphigoid is a chronic blistering skin disease affecting mucous membranes and skin, often leading to scarring. Early diagnosis and treatment, including topical therapies and systemic corticosteroids or dapsone, improve outcomes.

Area of Science:

  • Dermatology
  • Immunodermatology
  • Autoimmune Blistering Diseases

Background:

  • Cicatricial pemphigoid is a subepidermal blistering disease primarily affecting elderly individuals.
  • It commonly involves oral mucosa and eyes, leading to chronic inflammation and potentially severe scarring.
  • Pathogenesis involves in vivo deposition of anti-basement membrane zone antibodies, though circulating antibodies are not routinely detected.

Purpose of the Study:

  • To summarize the key characteristics, diagnostic considerations, and management strategies for cicatricial pemphigoid.
  • To emphasize the importance of differentiating cicatricial pemphigoid from other vesiculobullous disorders.
  • To highlight the role of early intervention in improving patient prognosis.

Main Methods:

Related Experiment Videos

  • Review of clinical features, immunopathology, and treatment modalities for cicatricial pemphigoid.
  • Comparison with differential diagnoses such as bullous pemphigoid and epidermolysis bullosa acquisita.
  • Analysis of therapeutic approaches including topical agents, intralesional corticosteroids, systemic corticosteroids, dapsone, and immunosuppressants.

    • Main Results:

    • Cicatricial pemphigoid is characterized by chronic, scarring inflammation, predominantly in elderly patients.
    • Diagnosis requires differentiation from other blistering diseases, as circulating antibodies are not typically found.
    • Treatment involves a stepwise approach, often starting with topical therapies and progressing to systemic agents like corticosteroids, dapsone, or immunosuppressants.

    Conclusions:

    • Early recognition and appropriate treatment of cicatricial pemphigoid are crucial for preventing significant scarring and improving prognosis.
    • A combination of therapies, tailored to disease severity and patient tolerance, is often necessary.
    • Further research into the poorly understood pathogenesis may lead to novel therapeutic targets.